Olivier Danhaive

Prof. Olivier Danhaive


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Seminars in Fetal and Neonatal Medicine
Verified
Journal Article
Closed access
MNMaureen Peers de Nieuwburgh
Maureen Peers de Nieuwburgh
JWJennifer Wambach
Jennifer Wambach
MGMatthias Griese
Matthias Griese
ODOlivier Danhaive
Olivier Danhaive

28 December 2023 in Clinics in Perinatology
Verified
Journal Article
Closed access
ODOlivier Danhaive
Olivier Danhaive
CGCsaba Galambos
Csaba Galambos
SLSatyan Lakshminrusimha
Satyan Lakshminrusimha
SASteven H. Abman
Steven H. Abman

1 April 2022 in Children
Verified
Journal Article
Open access
PDF file
ICIrma Capolupo
Irma Capolupo
DRDomenico Umberto De Rose
Domenico Umberto De Rose
RPRoberto Pascone
Roberto Pascone
ODOlivier Danhaive
Olivier Danhaive
MOMarcello Orzalesi
Marcello Orzalesi
Neonates are highly susceptible to bacterial infections, which represent a major source of mortality and morbidity in this age category. It is recognized that β2 integrins play a critical role in innate immunity by mediating leukocyte vascular adhesion, transmigration and bacterial phagocytosis. Therefore, we aimed to assess if the impaired immune functions seen in newborns may derive, in part, from a transient insufficient β2 integrin expression. In the present study we measured baseline lymphocyte function-associated antigen-1 (LFA-1 or CD11a/CD18), macrophage-1 antigen (MAC-1 or CD11b/CD18) and leukocyte integrin p150-95 (CD11c/CD18) expression on cord blood, and on the third day of life in a cohort of 35 healthy neonates, compared with a control group of 12 healthy adults. For any of the three β2 integrins, the expression on polymorphonuclear cells was significantly lower on cord blood than in adults and increased from birth to day 3. We also compared superoxide radical (SR) production in these neonates with 28 non-smoking adults. SR production in response to integrin stimulation by Zymosan was significantly lower at birth than in adults, and it decreased further in the third day of life. These findings suggest that innate immune impairment in newborns may be, in part, accounted for by a lower β2 integrin expression on phagocytes in the neonatal period, but also by a functional impairment of free radical production.

1 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
DRDomenico Umberto De Rose
Domenico Umberto De Rose
IBIliana Bersani
Iliana Bersani
GSGugliemo Salvatori
Gugliemo Salvatori
FCFrancesca Campi
Francesca Campi
LMLudovica Martini
Ludovica Martini
FPfiammetta piersigilli
fiammetta piersigilli
Background: Enteral feeding during therapeutic hypothermia (TH) for hypoxic–ischemic encephalopathy (HIE) remains heterogeneous across centres because of concerns regarding feeding intolerance and the risk of necrotizing enterocolitis (NEC). Evidence regarding optimal feeding initiation and advancement remains limited. Methods: We performed a secondary analysis of a multicentre retrospective cohort of infants with HIE treated with TH at two tertiary neonatal intensive care units in Italy and Belgium between 2011 and 2024. We included survivors with complete nutritional data, aware that this restriction, adopted because feeding-related endpoints cannot be assessed in non-survivors, may introduce survivor bias. Feeding practices, enteral feeding progression, feeding tolerance, and gastrointestinal outcomes were evaluated. Results: Of 302 infants in the original cohort, 276 were included. Enteral feeding during TH was administered to 166 infants (60.1%). Enteral feeding volumes remained low during the first three days of life but progressively increased thereafter. Despite inter-center differences in feeding strategies (initiation and advancement), time to full enteral feeding (median 9 days; IQR 7–12) was comparable overall (Italy: median 9 days, IQR 7–12; Belgium: median 10 days, IQR 7–14; p = 0.323). Infants receiving enteral nutrition during TH were observed to achieve full enteral feeding earlier than those not fed during cooling (median 8.0 vs. 12.0 days, p < 0.001) and to have a shorter length of hospital stay (median 11.0 vs. 15.0 days, p < 0.001). Breastfeeding at discharge was also observed more frequently among infants who received enteral nutrition during TH (79.5% vs. 54.5%, p < 0.001). Feeding intolerance occurred in 47 infants (17.0%) and temporary feeding withdrawal in 31 (11.2%). Only three infants (1.1%) developed Bell stage IIA NEC, with no progression to more advanced disease or surgery. NEC was more frequent among infants with Sarnat stage III HIE than among those with stage I–II disease (8.3% vs. 0.4%, p = 0.022). Conclusions: Enteral feeding during TH was feasible, and gastrointestinal complications were uncommon. These findings support the feasibility of cautious enteral feeding during TH. The concentration of NEC events among infants with severe HIE, although based on only three cases, is hypothesis-generating and suggests that future studies should evaluate feeding strategies according to both neurological severity and physiological stability. Whether earlier initiation or faster advancement is beneficial in clinically stable infants cannot be determined from these observational data and should be addressed in prospective studies.